+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 18Years - 95Years
All Genders
ID05965453

Safety and Effectiveness of the Castor Single Branch Stent Graft for Treating Acute Aortic Syndrome

Led by First Affiliated Hospital Xi'an Jiaotong University · Updated on 2023-07-28

205

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating the safety and effectiveness of the Castor single branch stent graft for treating patients with acute aortic syndrome who have an inadequate proximal landing zone less than 15 mm. This observational, ambispective, multicenter cohort study focuses on those who underwent thoracic endovascular aortic repair with this device between June 2018 and June 2022. The study includes 205 patients who received the Castor single branch stent graft. Patients had follow-up visits at 1 month, 6 months, and 1 year after the procedure for physical exams, laboratory tests, and CT angiography assessments. They will continue returning for follow-ups at 2 years, 3 years, and annually up to 10 years to monitor their condition and the performance of the stent graft. Participants will undergo evaluations including imaging scans to track aortic remodeling, check for adverse events related to the device or procedure, and monitor for any need for re-intervention. The main outcomes measured are immediate success of the procedure, mortality, and major complications within 1 year, along with ongoing long-term safety and effectiveness. The total follow-up duration can extend up to 10 years post-procedure.

CONDITIONS

Brief Title

Evaluation of the Castor Single Branch Stent Graft in Treatment of Acute Aortic Syndrome

Research Team

H

Hongyan Tian, MD

M

Mengyang Kang, MD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here